IFN-γ enzyme-linked immunospot (ELISPOT) assays were performed as previously described [36]. In brief, PBMCs were plated in 96-well plates that were precoated with anti-IFN-γ monoclonal antibody at 100,000 cells per well with peptides at a final concentration of 5 μg/ml for pooled peptides, single peptides, and optimal epitopes (BDTM ELISPOT, USA). Phytohemagglutinin (PHA) served as a positive control at a concentration of 10 μg/ml, and medium alone was the negative control. Spots were counted using the ImmunoSpot® Analyzer (Cellular Technology Ltd, USA), and the number of specific T-cells was counted by subtracting the mean negative control values. Responses were considered positive if the activity was at least three times greater than the mean number of spot-forming cells (SFCs) in the negative control as well as >50 SFCs per 106 PBMCs.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.